Hepatic arterial infusion chemotherapy for unresectable liver metastases of colorectal cancer: a multicenter retrospective study

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter A. Lim
Citation Annals of Oncology (2016) 27 (2): 1-85. 10.1093/annonc/mdw199
Authors A. Lim1, S. Le Sourd2, H. Senellart3, D. Luet4, F. Douane1, C. Perret1, A. Bouvier4, S. Métairie1, E. Cauchin1, R. Philippe5, M. Tamara6, Y. Touchefeu1
  • 1NantesUniversity Hospital, Nantes, N/A, /
  • 2Oncology Center Eugène Marquis, Rennes, N/A, /
  • 3Institut de cancérologie de l'Ouest René Gauducheau, St-Herblain, N/A, /
  • 4Angers University Hospital, Angers, N/A, /
  • 5Hopital Europeen Georges Pompidou, Paris, Paris, /
  • 6C.H.U. Hôtel Dieu, Nantes Cedex 1, /

Abstract

Hepatic arterial infusion chemotherapy (HAIC) is a treatment used for isolated liver metastases (LM), mainly of colorectal cancer (CRC) origin. Because of its technical conditions, it is used in only few experienced centers in France. Our aim was to evaluate its feasibility, efficacy and tolerance in 4 centers which have recently developed HAIC.